The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects
出版年份 2015 全文链接
标题
The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects
作者
关键词
-
出版物
Future Microbiology
Volume 10, Issue 10, Pages 1579-1598
出版商
Future Medicine Ltd
发表日期
2015-10-06
DOI
10.2217/fmb.15.91
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months
- (2015) Fiona McQuaid et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines
- (2015) Ernesto Oviedo-Orta et al. VACCINE
- Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction
- (2015) Rebecca A. Gladstone et al. VACCINE
- Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
- (2015) Marcello Tirani et al. PLoS One
- Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years
- (2014) R. Gasparini et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
- (2014) Robert C Read et al. LANCET
- The Clinical Features and Long-term Sequelae of Invasive Meningococcal Disease in Children
- (2014) Chen Stein-Zamir et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)
- (2014) Roman Prymula et al. Human Vaccines & Immunotherapeutics
- Acceptability of meningococcal serogroup B vaccine among parents and health care workers in Italy: A survey
- (2014) Chiara Mameli et al. Human Vaccines & Immunotherapeutics
- Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
- (2013) M. D. Snape et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Genetic Distribution of Noncapsular Meningococcal Group B Vaccine Antigens in Neisseria lactamica
- (2013) Jay Lucidarme et al. Clinical and Vaccine Immunology
- A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?
- (2013) Natalie G Martin et al. Expert Review of Vaccines
- Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
- (2013) Timo Vesikari et al. LANCET
- Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
- (2013) Ulrich Vogel et al. LANCET INFECTIOUS DISEASES
- Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster Doses
- (2013) Matthew D. Snape et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact
- (2013) Hannah Christensen et al. VACCINE
- Effectiveness of meningococcal serogroup C vaccine programmes
- (2013) Ray Borrow et al. VACCINE
- Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
- (2013) Giacomo Frosi et al. VACCINE
- Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)
- (2013) Julie A. Bettinger et al. VACCINE
- Persistence of antibodies in adolescents 18−24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine
- (2013) Maria Elena Santolaya et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules
- (2012) Nicoletta Gossger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
- (2012) María Elena Santolaya et al. LANCET
- Effect of vaccines on bacterial meningitis worldwide
- (2012) Peter B McIntyre et al. LANCET
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
- (2012) Davide Serruto et al. VACCINE
- Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
- (2012) Eva Hong et al. VACCINE
- Neisseria meningitidisB vaccines
- (2011) Donatella Panatto et al. Expert Review of Vaccines
- Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults
- (2011) Daniela Toneatto et al. Human vaccines & immunotherapeutics
- The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans
- (2011) Daniela Toneatto et al. Human vaccines & immunotherapeutics
- The changing and dynamic epidemiology of meningococcal disease
- (2011) Scott A. Halperin et al. VACCINE
- Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine
- (2011) Heike Claus et al. VACCINE
- The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
- (2010) Vanessa N Racloz et al. BMC INFECTIOUS DISEASES
- Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM197Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal Isolates
- (2010) Alan Kimura et al. Clinical and Vaccine Immunology
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Serogroup B meningococcal vaccines—an unfinished story
- (2010) Manish Sadarangani et al. LANCET INFECTIOUS DISEASES
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
- (2010) J. Donnelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
- (2009) Carl E. Frasch et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started